AI assistant
INSMED Inc — Director's Dealing 2025
Aug 18, 2025
30150_dirs_2025-08-18_8df0da8f-c06b-4842-acd0-d57efcdd0c22.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-08-14
Reporting Person: Schaeffer Orlov S Nicole (Chief People Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-14 | Common Stock | S | 3554 | $126.57 | Disposed | 86210 | Direct |
| 2025-08-14 | Common Stock | S | 5746 | $127.71 | Disposed | 80464 | Direct |
| 2025-08-14 | Common Stock | S | 700 | $128.16 | Disposed | 79764 | Direct |
Footnotes
F1: This is the weighted average sales price representing 3,554 shares sold at prices ranging from $126.01 to $126.94 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F2: Includes 357 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F3: This is the weighted average sales price representing 5,746 shares sold at prices ranging from $127.08 to $128.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 700 shares sold at prices ranging from $128.10 to $128.24 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.